
Stoke Therapeutics, Inc.
USD28.81
+1.13 (+4.08%)
CEO
Ian F. Smith
IPO Date
2019-06-19
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$27.66
Prev. Close
$27.68
Day Low
$27.23
Day High
$29.05
52W Low
$12.25
52W High
$40.22
Market Cap
$1.79B
Volume
0.54M
| Wedbush |
| Outperform |
| Outperform |
| maintain |
| 18 Mar 2026 | Chardan Capital | Buy | Buy | maintain |
| 17 Mar 2026 | Wedbush | Outperform | Outperform | maintain |
| 17 Mar 2026 | Needham | Buy | Buy | maintain |
| 12 Jan 2026 | Wedbush | Outperform | Outperform | maintain |
| 5 Jan 2026 | Canaccord Genuity | Buy | Buy | maintain |
| 5 Jan 2026 | Chardan Capital | Buy | Buy | maintain |